Doppelgerz® asset "Vitamins for the eyes with chromium, zinc and selenium"

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.E.000766.02.17
Date of registration and renewal:16.02.2017
Dosage form: & nbspCapsules with a mass of 1350 mg.
Classification "Composition" & nbsp BAD - vitamin and mineral complexes BADs - fats, fatty substances and their derivatives BAD - products of plant, animal or mineral origin
Classification "Clinical" & nbsp BAD-sources of multivitamins containing individual minerals and mineral complexes BAA sources of fatty acids Supplements containing zinc, copper, manganese Supplements containing chromium Supplements containing selenium
Composition: & nbspFish oil, gelatin, E422, E420, alpha-lipoic acid, ascorbic acid, soybean oil bean, lutein suspension, glycerol monostearate, dry extract of bilberry fruit wax yellow, vitamin E, lecithin, zeaxanthin, zinc oxide, vitamin B1, iron oxides black, yellow and red, vitamin A palmitate, folic acid, chromium chloride, sodium selenite.
Scope: & nbspTo implement the public as a dietary food supplement - source of lutein, zeaxanthin, alpha-lipoic acid, an additional source of vitamins A, E, C, B1, folic acid, chromium, zinc, and selenium.
Suggested Usage: & nbspAdults take 1 capsule 1 time per day with meals. Duration of admission is 1 month. After a break of 1 month, a second appointment is possible.
Contraindications:Individual intolerance to food components, pregnancy, lactation.Contains sorbitol, with excessive use can have a laxative effect.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions:Store in a dry place inaccessible to children at a temperature not exceeding + 25 ° С.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.11.003.E.000387.01.17 of 31.01.2017, expert opinions of the FBUC of the Federal Targeted Register and the Federal Service for Consumer Rights Protection No. 10-2FTS / 2934 of 02.07.2014, No. 10-2FTS / 1938 from 08/12/2016.
Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation
Information update date: & nbsp13.03.2017
Instructions
Up